The Food and Drug Administration approved Gilead's twice-yearly antiviral drug for preventing HIV. The company and some experts say it is a milestone that could help bring the world closer to ending ...

AUSTIN (KXAN) — Advocates for HIV prevention are calling a newly approved injectable medication a major step in eliminating the spread of the virus. This summer, the FDA approved Gilead’s lenacapavir, ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. Gilead Sciences, maker of the drug, ...

A clinical trial has found an injectable HIV treatment could be an effective prevention for the infection, NPR reported July 3. A clinical trial by drugmaker Gilead conducted a randomized study on ...

Doctors at DAP Health have begun administering a new twice-a-year injectable HIV prevention medication, which was approved by the Food and Drug Administration in June. Gilead's drug lenacapavir ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Only two people taking twice-yearly lenacapavir in a ...

(CNN) — A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. (CNN) — A drug currently ...